NDC 67457-228-00 - Rocuronium Bromide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67457-228
- Requested NDC
- 67457-228-00
- Package NDCs from labels
- 67457-228-00, 67457-228-05, 67457-228-99, 67457-228-10
- Manufacturer
- Mylan Institutional LLC
- Effective date
- 2025-08-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rocuronium Bromide - Mylan Institutional LLC | Mylan Institutional LLC | 2025-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67457-228-00 | Rocuronium Bromide | 5 mL in 1 VIAL, MULTI-DOSE | INJECTION | 5 | 19 | |
| 67457-228-05 | Rocuronium Bromide | 10 in 1 CARTON | INJECTION | 10 | 19 | |
| 67457-228-10 | Rocuronium Bromide | 10 in 1 CARTON | INJECTION | 10 | 19 | |
| 67457-228-99 | Rocuronium Bromide | 10 mL in 1 VIAL, MULTI-DOSE | INJECTION | 10 | 19 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67457-228-00 | ML - Milliliter | 67457-228 | c38710d8-fab9-4f8f-9c37-72de92bea215 | 1 | 2014-01-04 |
| 67457-228-05 | ML - Milliliter | 67457-228 | b21188ba-3785-4775-9a26-4e540be7a7c8 | 1 | 2012-07-24 |
| 67457-228-10 | ML - Milliliter | 67457-228 | 01f8565f-978a-4f2f-8271-caf70fca38f6 | 1 | 2012-07-24 |
| 67457-228-99 | ML - Milliliter | 67457-228 | de88ca13-4b81-40c6-860b-367041759e73 | 1 | 2014-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ROCURONIUM BROMIDE | ACTIVE INGREDIENT | I65MW4OFHZ | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 | |
| ROCURONIUM | ACTIVE MOIETY | WRE554RFEZ | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 | |
| ACETIC ACID | INACTIVE INGREDIENT | Q40Q9N063P | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 | |
| SODIUM ACETATE | INACTIVE INGREDIENT | 4550K0SC9B | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| ROCURONIUM BROMIDE | ROCURONIUM BROMIDE | Medical Purchasing Solutions, LLC | 5cca80f6-a4d1-3b1c-e063-6394a90a75b3 | 2026-10-01 | Warnings, Adverse reactions | 1234995 I65MW4OFHZ |
| Rocuronium Bromide | ROCURONIUM BROMIDE | Baxter Healthcare Corporation | a18fce42-0f3d-4354-845e-57c37ac3a147 | 2026-10-01 | Warnings, Adverse reactions | I65MW4OFHZ |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| Rocuronium Bromide | ROCURONIUM BROMIDE | Sagent Pharmaceuticals | 01825411-be08-4402-b101-cb546291c972 | 2026-09-22 | Warnings, Adverse reactions | 1234995 I65MW4OFHZ |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| HEB Saline | NASAL | HEB | 520e20a3-1e16-4cbd-9da3-948747f4f51d | 2026-09-18 | Warnings | 451W47IQ8X |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
| Saline | SALINE | FAMILY DOLLAR SERVICES INC | 7d2acfff-e55b-48b9-9d36-4975563e08ff | 2026-09-17 | Warnings | 451W47IQ8X |
| Saline | NASAL | Raritan Pharmaceuiticals Inc | 4b178e4e-a10f-4b75-8140-1f7548e203ad | 2026-09-09 | Warnings | 451W47IQ8X |
| Thyroid Support | CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE) | NaturalCare | 07b4e0ed-2b00-4d0a-ad8f-fc6deff15325 | 2026-09-08 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.